Cardiology
Partner With Us
Advertisement
Conexiant chevron_right Cardiology chevron_right Primary Prevention Aspirin Use Declines Post 2019 Guidelines
From the Journals Clinical Guidelines

Primary Prevention Aspirin Use Declines Post-2019 Guidelines

"Following landmark clinical trials and changes in guideline recommendations, self-reported primary prevention aspirin use decreased among older adults and adults with low ASCVD risk for whom aspirin was not recommended, but also decreased among adults with higher ASCVD risk for whom aspirin may still be recommended."

Conexiant
article Full Article subject Summary summarize Notecard
  1. Primary prevention aspirin use decreased significantly among U.S. adults following updated clinical guidelines.
  2. Reduction in aspirin use was most pronounced among older adults and those with low atherosclerotic cardiovascular disease (ASCVD) risk.
  3. Stable rates of secondary prevention aspirin use were observed throughout the study period.
  4. The study revealed disparities in aspirin use reduction across demographic groups.
  5. Limitations of the research included reliance on self-reported aspirin use and falling response rates in NHANES surveys.

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.